What is CarboCode?
CarboCode is a specialized biotechnology research and development firm dedicated to advancing glycan-based therapeutics and diagnostics. Leveraging expertise in carbohydrate chemistry and glycobiology, the company targets significant unmet needs in oncology, immunology, and infectious diseases. CarboCode offers comprehensive contract research services, including the custom synthesis of complex carbohydrates, and is actively developing its own pipeline of proprietary glycan-based drug candidates. Their advanced technology platform is instrumental in designing and synthesizing intricate oligosaccharides for pharmaceutical and diagnostic applications, positioning them as a key player in the precision medicine landscape.
How much funding has CarboCode raised?
CarboCode has raised a total of $33M across 2 funding rounds:
Series C
$15.7M
Series C
$17.3M
Series C (2024): $15.7M with participation from Iberis Capital
Series C (2025): $17.3M led by Iberis Capital
Key Investors in CarboCode
Iberis Capital
Iberis Capital is a prominent Portuguese private equity and venture capital manager with over €600 million in assets under management. They focus on innovation and growth, supporting both early-stage and established companies with a high-performance team dedicated to delivering strong returns.
What's next for CarboCode?
With the recent major strategic investment, CarboCode is poised for accelerated growth and expansion. The company is expected to channel these resources into further enhancing its proprietary technology platform, expanding its research and development capabilities, and potentially initiating new clinical trials for its drug candidates. This strategic financing will likely bolster CarboCode's efforts to forge new partnerships within the pharmaceutical industry and solidify its market position as a leader in glycan-based innovation. The company's focus on high-impact therapeutic areas suggests a trajectory aimed at significant clinical and commercial milestones.
See full CarboCode company page
